David C. Nickle

TL;DR: In this article, the authors found incomplete recoveries of CD4 + T cells in the GALT of aviremic, HIV-infected individuals who had received up to 9.9 years of effective antiretroviral therapy.

TL;DR: Patients with HCV infection who were receiving OAT and treated with elbasvir-grazoprevir had high rates of SVR12, regardless of ongoing drug use, and these results support the removal of drug use as a barrier to interferon-free HCV treatment for patients receiving Oat.

TL;DR: The identification of AKAP13 as a susceptibility gene for IPF increases the prospect of successfully targeting RhoA pathway inhibitors in patients with IPF.

TL;DR: It is found that substantial shared genetic architecture between mild and moderate-to-severe asthma is found and candidate causal genes in these loci are identified and provide increased insight into this difficult to treat population.

TL;DR: An intensive longitudinal study of viral genetic changes and T-cell immunity in one subject at ≤17 time points during his first 3 years of infection and in his infecting partner near the time of transmission confirmed CTLs as a dominant selective force in HIV-1 infection.